You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for MUCUS RLF DM ER


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MUCUS RLF DM ER

Average Pharmacy Cost for MUCUS RLF DM ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MUCUS RLF DM ER 600-30 MG TAB 00536-1161-37 0.43475 EACH 2025-01-22
MUCUS RLF DM ER 600-30 MG TAB 70000-0491-01 0.43475 EACH 2025-01-22
MUCUS RLF DM ER 600-30 MG TAB 00536-1161-34 0.43475 EACH 2025-01-22
MUCUS RLF DM ER 600-30 MG TAB 70000-0491-01 0.43979 EACH 2024-12-18
MUCUS RLF DM ER 600-30 MG TAB 00536-1161-37 0.43979 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Mucus Relief DM ER

Overview of Mucus Relief DM ER

Mucus Relief DM ER, a combination of dextromethorphan and guaifenesin, is a widely used over-the-counter (OTC) medication for relieving cough and breaking up mucus. This drug falls under the upper respiratory combinations drug class and is commonly prescribed for symptoms associated with the common cold, flu, and other respiratory conditions.

Market Size and Growth

The global expectorant drugs market, which includes Mucus Relief DM ER, is projected to experience significant growth over the coming years. Here are some key market insights:

  • Global Market Value: The expectorant drugs market is estimated to be valued at US$ 17,648.2 million in 2024 and is projected to reach US$ 38,455.4 million by 2034, growing at a CAGR of 4.3% during the forecast period[3].
  • Regional Growth: The Asia Pacific region is expected to be the fastest-growing market, while North America is anticipated to remain the largest market due to the high prevalence of respiratory diseases and the presence of key pharmaceutical players[4].

Drivers of Market Growth

Several factors are driving the growth of the expectorant drugs market, including:

  • Respiratory Health Awareness: The COVID-19 pandemic has highlighted the importance of maintaining good respiratory health, leading to increased demand for expectorants like Mucus Relief DM ER[3].
  • Prevalence of Respiratory Diseases: Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory ailments are common, particularly among smokers and the elderly, which increases the demand for expectorant medications[4].
  • Advances in Medical Research: The potential use of monoclonal antibodies, gene therapies, and personalized medicine could enhance the effectiveness of expectorants, further boosting market growth[3].

Price Projections for Mucus Relief DM ER

The prices of Mucus Relief DM ER can vary based on the dosage form, quantity, and pharmacy. Here are some current price ranges:

  • Oral Tablet, Extended Release:
    • For a 30 mg-600 mg dosage, the price ranges from $13.07 for 20 tablets to $16.65 for 40 tablets[2].
    • For a 60 mg-1200 mg dosage, the price ranges from $16.78 for 14 tablets to $28.19 for 28 tablets[2].

Pricing Trends

  • Discounts and Coupons: Consumers can use discount cards, such as the Drugs.com Discount Card, to save up to 80% on the cost of Mucus Relief DM ER and other medications[2][5].
  • Generic Versions: The availability of generic versions of Mucus Relief DM ER can also impact pricing, making the medication more affordable for consumers[2][5].

Distribution and Availability

Mucus Relief DM ER is widely available at most major pharmacies, including Walgreens, CVS Pharmacy, Target, Walmart Pharmacy, and Duane Reade. The drug can be purchased with or without insurance, and prices may vary depending on the pharmacy and any applicable discounts or coupons[2][5].

Market Restraints

Despite the positive growth projections, there are some restraints to consider:

  • Stringent Regulations: Regulatory restrictions on the use of cough suppressants could affect the global market growth of cough suppressant drugs, including those containing guaifenesin[1].
  • Supply Chain Issues: The surge in demand for expectorants during pandemics and flu outbreaks can strain supply chains, leading to potential shortages of these medications[4].

Future Outlook

The future outlook for Mucus Relief DM ER and the broader expectorant drugs market is promising. Here are some key points:

  • Increasing Demand: The demand for expectorants is expected to rise due to growing awareness of respiratory health and the increasing prevalence of respiratory diseases[3][4].
  • Technological Advancements: Advances in drug delivery systems, such as nanotechnology, and personalized medicine could enhance the effectiveness and safety of expectorant medications, further driving market growth[3].

Key Takeaways

  • The global expectorant drugs market, including Mucus Relief DM ER, is projected to grow significantly over the next decade.
  • Factors such as increased awareness of respiratory health, prevalence of respiratory diseases, and advances in medical research are driving market growth.
  • Prices for Mucus Relief DM ER vary based on dosage and quantity, with discounts and generic versions available to reduce costs.
  • The market faces restraints such as stringent regulations and potential supply chain issues.

FAQs

What is Mucus Relief DM ER used for?

Mucus Relief DM ER is used to relieve cough and break up mucus associated with the common cold, flu, and other respiratory conditions.

How much does Mucus Relief DM ER cost?

The cost of Mucus Relief DM ER varies based on the dosage form and quantity. For example, a 30 mg-600 mg extended-release tablet can cost around $13.07 for 20 tablets.

Are there any discounts available for Mucus Relief DM ER?

Yes, consumers can use discount cards, such as the Drugs.com Discount Card, to save up to 80% on the cost of Mucus Relief DM ER.

What are the key drivers of the expectorant drugs market?

Key drivers include increased awareness of respiratory health, the prevalence of respiratory diseases, and advances in medical research.

Which region is expected to dominate the expectorant drugs market?

North America is expected to dominate the market due to the high prevalence of respiratory diseases and the presence of key pharmaceutical players.

Sources

  1. Allied Market Research: Guaifenesin Market Size, Trends | Industry Report 2021 - 2030
  2. Drugs.com: Mucus Relief DM Prices, Coupons, Copay Cards & Patient Assistance
  3. Future Market Insights: Global Expectorant Drugs Market Growth Projection 2024-2034
  4. Mordor Intelligence: Expectorant Drugs Market Size & Share Analysis
  5. Drugs.com: Dextromethorphan/guaifenesin Prices, Coupons, Copay Cards & Patient Assistance

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.